AEB-2109

N/A

Report date: 2025/01/26 15:51:08

Base Information

Drug NameAEB-2109
Drug Alias NameAEMaseL-methionine degrading enzymes (Aeglea Biotherapeutics)engineered human methioninase enzyme (Aeglea BioTherapeutics)L-methionine degrading enzymes (University of Texas System)AEB-2109
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionEnzymes inhibitors
TargetsEnzymes
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Texas System
China Registration ClassN/A

Develop Information

Active CompaniesSpyre Therapeutics Inc
Inactive CompaniesUniversity Of Texas System
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A